BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2568263)

  • 1. [3H]SCH 23390 labels a novel 5-hydroxytryptamine binding site in human blood platelet membranes.
    De Keyser J; Walraevens H; Convents A; Ebinger G; Vauquelin G
    Eur J Pharmacol; 1989 Mar; 162(3):437-45. PubMed ID: 2568263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What intracranial tissues in humans contain sumatriptan-sensitive serotonin 5-HT1-type receptors?
    De Keyser J; Vauquelin G; De Backer JP; De Vos H; Wilczak N
    Neurosci Lett; 1993 Dec; 164(1-2):63-6. PubMed ID: 8152617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [3H]SCH 23390 labels dopamine D-1 receptor sites in the rat kidney.
    Zdilar D; Lacković Z
    Eur J Pharmacol; 1989 May; 164(1):159-62. PubMed ID: 2568936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of multiple binding sites for [3H]5-hydroxytryptamine in the rat CNS.
    Blurton PA; Wood MD
    J Neurochem; 1986 May; 46(5):1392-8. PubMed ID: 3958711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two distinct serotonin receptors: regional variations in receptor binding in mammalian brain.
    Peroutka SJ; Snyder SH
    Brain Res; 1981 Mar; 208(2):339-47. PubMed ID: 7214150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The D-1 dopamine receptor antagonist SCH 23390 also interacts potently with brain serotonin (5-HT2) receptors.
    Bischoff S; Heinrich M; Sonntag JM; Krauss J
    Eur J Pharmacol; 1986 Oct; 129(3):367-70. PubMed ID: 3536532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5HT-receptor antagonist properties of SCH 23390 in vascular smooth muscle and brain.
    Hicks PE; Schoemaker H; Langer SZ
    Eur J Pharmacol; 1984 Oct; 105(3-4):339-42. PubMed ID: 6150862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of the binding of [3H]-GR32191 to the thromboxane (TP-) receptor of human platelets.
    Armstrong RA; Humphrey PP; Lumley P
    Br J Pharmacol; 1993 Oct; 110(2):539-47. PubMed ID: 8242228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
    Hoyer D; Engel G; Kalkman HO
    Eur J Pharmacol; 1985 Nov; 118(1-2):13-23. PubMed ID: 2935410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of the D1 receptor antagonist SCH 23390 with the central 5-HT system: radioligand binding studies, measurements of biochemical parameters and effects on L-5-HTP syndrome.
    Bischoff S; Heinrich M; Krauss J; Sills MA; Williams M; Vassout A
    J Recept Res; 1988; 8(1-4):107-20. PubMed ID: 3290470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of alpha 2-adrenoceptors in rat cortex but not human platelets can be defined by 8-OH-DPAT, RU 24969 and methysergide.
    Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
    Br J Pharmacol; 1990 Mar; 99(3):481-6. PubMed ID: 1970497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT1 and 5-HT2 binding profiles of the serotonergic agents alpha-methylserotonin and 2-methylserotonin.
    Ismaiel AM; Titeler M; Miller KJ; Smith TS; Glennon RA
    J Med Chem; 1990 Feb; 33(2):755-8. PubMed ID: 2299641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of the interaction of sertraline with the human platelet plasma membrane 5-hydroxytryptamine carrier.
    Phillips OM; Wood KM; Williams DC
    Eur J Pharmacol; 1988 Feb; 146(2-3):299-306. PubMed ID: 3371401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mianserin-induced up-regulation of serotonin receptors on normal human platelets in vivo.
    Whiteford HA; Jarvis MR; Stedman TJ; Pond S; Csernansky JG
    Life Sci; 1993; 53(4):371-6. PubMed ID: 8326822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of [3H]dihydrotetrabenazine and [125I]azidoiodoketanserin photoaffinity labeling of the monoamine transporter of platelet 5-HT organelles.
    Cesura AM; Bertocci B; Da Prada M
    Eur J Pharmacol; 1990 Sep; 186(1):95-104. PubMed ID: 2149340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical profile of risperidone, a new antipsychotic.
    Leysen JE; Gommeren W; Eens A; de Chaffoy de Courcelles D; Stoof JC; Janssen PA
    J Pharmacol Exp Ther; 1988 Nov; 247(2):661-70. PubMed ID: 2460616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the 5-HT1C receptor expressed in Xenopus oocytes by the benzazepines SCH 23390 and SKF 38393.
    Briggs CA; Pollock NJ; Frail DE; Paxson CL; Rakowski RF; Kang CH; Kebabian JW
    Br J Pharmacol; 1991 Dec; 104(4):1038-44. PubMed ID: 1687364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of [3H]SCH 23390 to dopamine D-1 receptors in rat retina in vitro.
    Gredal O; Parkinson D; Nielsen M
    Eur J Pharmacol; 1987 Jun; 137(2-3):241-5. PubMed ID: 2886353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
    Makman MH; Dvorkin B
    Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [125I]SCH 23982, a 'selective' D-1 receptor antagonist, labels with high affinity 5-HT1C sites in pig choroid plexus.
    Hoyer D; Karpf A
    Eur J Pharmacol; 1988 May; 150(1-2):181-4. PubMed ID: 3402537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.